DRIO
DarioHealth Corp

3,513
Mkt Cap
$76.1M
Volume
146.00
52W High
$17.74
52W Low
$5.94
PE Ratio
-0.62
DRIO Fundamentals
Price
$11.26
Prev Close
$11.28
Open
$11.26
50D MA
$11.38
Beta
1.04
Avg. Volume
10,438.60
EPS (Annual)
-$12.27
P/B
1.02
Rev/Employee
$133,861.39
$40.11
Loading...
Loading...
News
all
press releases
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of +20.83% and +2.71%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15h ago
News Placeholder
More News
News Placeholder
Y.D. More Investments Ltd Reduces Stock Position in DarioHealth Corp. $DRIO
Y.D. More Investments Ltd trimmed its holdings in DarioHealth Corp. (NASDAQ:DRIO - Free Report) by 95.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·4d ago
News Placeholder
DarioHealth Corp. (NASDAQ:DRIO) Sees Large Decrease in Short Interest
DarioHealth Corp. (NASDAQ:DRIO - Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 30th, there was short interest totaling 64,677 shares...
MarketBeat·9d ago
News Placeholder
DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average - What's Next?
DarioHealth (NASDAQ:DRIO) Stock Passes Below 200 Day Moving Average - Here's What Happened...
MarketBeat·12d ago
News Placeholder
FY2025 EPS Forecast for DarioHealth Lowered by Analyst
DarioHealth Corp. (NASDAQ:DRIO - Free Report) - Equities research analysts at Litchfield Hills Research lowered their FY2025 EPS estimates for DarioHealth in a research report issued to clients and...
MarketBeat·30d ago
News Placeholder
DarioHealth (NASDAQ:DRIO) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen lowered DarioHealth from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·1mo ago
News Placeholder
Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's...
PR Newswire·1mo ago
News Placeholder
DarioHealth Corp. (NASDAQ:DRIO) Short Interest Update
DarioHealth Corp. (NASDAQ:DRIO - Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totaling 80,370 shares, an increase of 32.2...
MarketBeat·1mo ago
News Placeholder
DarioHealth (NASDAQ:DRIO) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen raised DarioHealth from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
DarioHealth (NASDAQ:DRIO) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell?
DarioHealth (NASDAQ:DRIO) Stock Crosses Below 200 Day Moving Average - Should You Sell...
MarketBeat·1mo ago
<
1
2
...
>

Latest DRIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.